SEC-sourced researchBeta
CODX
Co-Diagnostics, Inc.
Company comparison ↗
Data passport
- CIK
- 0001692415
- Exchange
- Nasdaq
- Business activity
- Surgical & Medical Instruments & Apparatus · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Nov 20, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 3,915,160.0000 | Mar 31, 2026 |
| December 2025 | 622,489.0000 | Mar 31, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 622,489.0000 | -46,895,936.0000 | -29,136,927.0000 | 24,742,585.0000 | 4,113,921.0000 | Mar 31, 2026 |
| December 2024 | 3,915,160.0000 | -37,639,008.0000 | -29,155,045.0000 | 63,563,158.0000 | 9,688,001.0000 | Mar 31, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
37/100
Profitability0
Growth0
Balance sheet83
Cash generation0
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $622.49K | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $3.92M | Jan 1, 2024 – Dec 31, 2024 | Mar 31, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$46.9M | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$29.14M | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Total assetsAssets | $24.74M | Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Total liabilitiesLiabilities | $4.11M | Dec 31, 2025 | Mar 31, 2026 | 10-K |
New filings
- 8-KCODX · Co-Diagnostics, Inc.Nov 20, 2026 · Current event
- 8-KCODX · Co-Diagnostics, Inc.Nov 19, 2026 · Current event
- 8-KCODX · Co-Diagnostics, Inc.Nov 13, 2026 · Current event
- 10-QCODX · Co-Diagnostics, Inc.Nov 10, 2026 · Periodic
- 8-KCODX · Co-Diagnostics, Inc.Nov 10, 2026 · Current event
- S-3CODX · Co-Diagnostics, Inc.Nov 4, 2026 · Other
- DEF 14ACODX · Co-Diagnostics, Inc.Oct 26, 2026 · Other
- PRE 14ACODX · Co-Diagnostics, Inc.Oct 16, 2026 · Other
- 8-KCODX · Co-Diagnostics, Inc.Oct 15, 2026 · Current event
- 8-K/ACODX · Co-Diagnostics, Inc.Oct 15, 2026 · Current event
- 8-KCODX · Co-Diagnostics, Inc.Oct 13, 2026 · Current event
- 8-KCODX · Co-Diagnostics, Inc.Oct 5, 2026 · Current event
- 8-KCODX · Co-Diagnostics, Inc.Sep 25, 2026 · Current event